NO20032581L - Farmasöytisk formulering av gepiron for oral administrering - Google Patents

Farmasöytisk formulering av gepiron for oral administrering

Info

Publication number
NO20032581L
NO20032581L NO20032581A NO20032581A NO20032581L NO 20032581 L NO20032581 L NO 20032581L NO 20032581 A NO20032581 A NO 20032581A NO 20032581 A NO20032581 A NO 20032581A NO 20032581 L NO20032581 L NO 20032581L
Authority
NO
Norway
Prior art keywords
gepirone
amount
weight
oral administration
certain amount
Prior art date
Application number
NO20032581A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032581D0 (no
Inventor
Johannes Gerardus Jos Egberink
John Francis Gelhart
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20032581L publication Critical patent/NO20032581L/no
Publication of NO20032581D0 publication Critical patent/NO20032581D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20032581A 2000-12-08 2003-06-06 Farmasöytisk formulering av gepiron for oral administrering NO20032581D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204388 2000-12-08
PCT/EP2001/014189 WO2002045753A2 (en) 2000-12-08 2001-11-30 Oral extended release formulation of gepirone

Publications (2)

Publication Number Publication Date
NO20032581L true NO20032581L (no) 2003-06-06
NO20032581D0 NO20032581D0 (no) 2003-06-06

Family

ID=8172397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032581A NO20032581D0 (no) 2000-12-08 2003-06-06 Farmasöytisk formulering av gepiron for oral administrering

Country Status (19)

Country Link
EP (1) EP1343504A2 (hu)
JP (1) JP2004517083A (hu)
KR (1) KR20040018314A (hu)
CN (1) CN1479620A (hu)
AR (1) AR031461A1 (hu)
AU (1) AU2002226371A1 (hu)
BR (1) BR0115976A (hu)
CA (1) CA2436692A1 (hu)
CZ (1) CZ20031589A3 (hu)
EC (1) ECSP034627A (hu)
HU (1) HUP0401021A2 (hu)
IL (1) IL155855A0 (hu)
MX (1) MXPA03005099A (hu)
NO (1) NO20032581D0 (hu)
PL (1) PL362445A1 (hu)
RU (1) RU2003120446A (hu)
SK (1) SK6942003A3 (hu)
WO (1) WO2002045753A2 (hu)
ZA (1) ZA200303915B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134193A1 (en) * 2002-09-24 2006-06-22 Pieter De Haan Method to improve pharmaceutical tablets having a matrix of cellulose ether
EA013213B1 (ru) * 2004-11-05 2010-04-30 Фэйбр-Крэймер Холдингз, Инк. Дозированная форма биоактивного метаболита гепирона с высокой дозировкой и длительным высвобождением, способ ее получения и способ лечения депрессии с ее использованием
JP7125978B2 (ja) * 2017-07-26 2022-08-25 アボット ラボラトリーズ 栄養タブレットおよびその製造方法
CN109745323A (zh) * 2017-11-01 2019-05-14 四川科瑞德制药股份有限公司 氮哌酮类化合物提高副交感神经活性的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form

Also Published As

Publication number Publication date
KR20040018314A (ko) 2004-03-03
MXPA03005099A (es) 2004-02-12
CA2436692A1 (en) 2002-06-13
JP2004517083A (ja) 2004-06-10
WO2002045753A2 (en) 2002-06-13
AR031461A1 (es) 2003-09-24
IL155855A0 (en) 2003-12-23
ZA200303915B (en) 2004-08-20
CZ20031589A3 (cs) 2003-11-12
CN1479620A (zh) 2004-03-03
AU2002226371A1 (en) 2002-06-18
WO2002045753A3 (en) 2002-08-29
BR0115976A (pt) 2003-12-30
EP1343504A2 (en) 2003-09-17
ECSP034627A (es) 2004-09-28
SK6942003A3 (en) 2003-10-07
PL362445A1 (en) 2004-11-02
NO20032581D0 (no) 2003-06-06
RU2003120446A (ru) 2005-02-20
HUP0401021A2 (hu) 2004-09-28

Similar Documents

Publication Publication Date Title
RS52577B (en) ONE-DAY OXYCODON FORMULATIONS
NO20050481L (no) Doseringsform av pramipexol for dosering en gang pr. dag
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
Tuite et al. Recent developments in the pharmacological treatment of Parkinson’s disease
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
MX2007000008A (es) Formas farmaceuticas orales, protegidas frente al abuso, que contienen (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil) fenol.
WO2001085257A3 (en) Opioid antagonist compositions and dosage forms
TW200505498A (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
BR9916361A (pt) Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
PL370529A1 (en) Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
ES2171440T3 (es) Composicion solida mucoadhesiva, terapeutica o higienica, para administracion por aplicacion sobre la mucosa bucal o nasal.
MX2008006037A (es) Drogas para el sistema nervioso central para administracion una-vez-al-dia.
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
CA2416771A1 (en) 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid for treatment of cox-2 dependent disorders
KR910014128A (ko) 칼시토닌의 경구투여용 약제학적 조성물 및 용량형
NO20032581L (no) Farmasöytisk formulering av gepiron for oral administrering
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
BR0207297A (pt) Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application